Arthur D. Little appoints Ulrica Sehlstedt to lead Global Healthcare & Life Sciences Practice
29.10.2019 12:38:00 EET | Business Wire | Press release
Arthur D. Little (ADL) today announced the appointment of Dr. Ulrica Sehlstedt as the new Global Practice Leader for its Global Healthcare & Life Sciences (HCLS) Practice.
With over 20 years of experience in the healthcare and life sciences sectors, Ulrica is a Partner based in ADL’s Stockholm office. She joined the company 13 years ago and has worked extensively for ADL clients across the healthcare and life sciences ecosystem; covering global industry players (pharma, medtech and biotech companies), healthcare providers (public and private), early stage life sciences companies and investors in the sector. Prior to joining ADL, she was CEO of a biotech start-up in molecular diagnostics and also has an extensive background in academic research.
ADL’s Global HCLS Practice works side-by-side with its clients to meet their challenges as the sector goes through an era of enormous medical and technological innovation, while delivering results in a more resource-constrained ecosystem. It achieves this through deep industry knowledge, combined with creative thinking. This enables ADL to work with its clients in harnessing innovation to overcome their most difficult strategic challenges.
Ulrica will take over from Nils Bohlin, who has successfully led the Global HCLS Practice for 8 years, nearly quadrupling its size. After a successful career of 37 years with ADL, Nils has reached retirement age, but will stay in close contact with the company in a new role as Senior Advisor.
Ignacio García Alves, Chairman and Chief Executive Officer at Arthur D. Little comments: “The healthcare and life sciences ecosystem is changing rapidly as innovation and digitalization radically disrupt the sector. At ADL we have already built a strong position in the market, and Ulrica’s leadership will drive further growth in the Global Healthcare & Life Sciences Practice, thanks to her wide experience, deep understanding and commitment to innovation.”
Dr. Ulrica Sehlstedt, Global Practice Leader, Global Healthcare & Life Sciences Practice at Arthur D. Little adds: “While innovation has always been central to healthcare, we are seeing unprecedented change as advances accelerate across the sector. At the same time available resources have not kept pace, meaning that balancing innovation and outcomes requires strategic understanding and market knowledge. ADL’s Global Healthcare and Life Sciences Practice is already perfectly positioned to help our clients meet these challenges, and I look forward to leading the team as the industry transforms.”
Ulrica holds a PhD in biophysics from Stockholm University, as well as an MSc in Chemical Engineering from Chalmers University of Technology, Gothenburg, Sweden. She has also been a member of the Swedish Research Council’s Scientific Council for Medicine for six years, and is regularly engaged in expert roles for life science research and industry initiatives directed towards governments and policy makers.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191029005489/en/
Contact information
Cate Bonthuys
Catalyst Comms
+44 7746 56773
cate@catalystcomms.co.uk
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
WHOOP Broadens WHOOP Advanced Labs Offering, Announcing a Women’s Health Specialized Blood Biomarker Panel10.3.2026 12:00:00 EET | Press release
WHOOP, the human performance company, today unveiled multiple initiatives and new clinically-backed features, including the coming launch of the company’s Women's Health Specialized Blood Biomarker Panel. Building on the WHOOP Advanced Labs Baseline Panel launched last year, the Women’s Health Specialized Blood Biomarker Panel adds 11 clinically backed, female-specific blood biomarkers that expand insight into areas that are frequently under-measured or misinterpreted in traditional women’s health testing. WHOOP has also announced a new Hormonal Symptom Insights and Predictions update, along with a comprehensive Menstrual Cycle White Paper detailing the science behind its cycle modeling. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310966566/en/ WHOOP Broadens WHOOP Advanced Labs Offering, Announcing a Women’s Health Specialized Blood Biomarker Panel These initiatives reflect the company’s commitment to advancing women’
Spring into Smarter Home Protection: EZVIZ Launches Standout Deals for the Amazon Spring Sale10.3.2026 11:30:00 EET | Press release
As the new season brings longer days and fresh beginnings, EZVIZ is turning up the excitement with a lineup of irresistible offers during the Amazon Spring Sale. Known for delivering easy-to-use smart security products, EZVIZ is giving households the perfect opportunity to refresh their home protection with technology designed for modern living. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310567932/en/ Spring into smarter home protection: EZVIZ launches standout deals for the Amazon Spring Sale As homes open up to the energy of spring, whether welcoming guests, receiving more deliveries, or simply spending more time outdoors, this seasonal sales on Amazon offers a timely chance to upgrade everyday security. During the Spring Sale, shoppers can enjoy limited-time savings on a curated selection of EZVIZ’s smart cameras and entryway products, making it easier to safeguard front doors, gardens, and outdoor spaces while emb
For the First Time, Ferring Reports Revenue of Over €2.5 Billion in 202510.3.2026 11:00:00 EET | Press release
Ferring today published its 2025 Annual Report and Sustainability Report. The company achieved total revenues of over €2.5 billion in 2025, an increase of 7% over the previous year at actual exchange rates (AER) and 10% at constant exchange rates (CER). These were mainly driven by our flagship product Menopur® (menotropins for injection) in reproductive medicine, and the ramp-up in the US of our breakthrough gene-based therapy for non-muscle invasive bladder cancer, Adstiladrin® (nadofaragene firadenovec-vncg). Operating expenses were contained to an increase of €61 million year-on-year (i.e. +5% at AER and +7% at CER), and this includes significant non-recurring items (notably impairment charges and restructuring provisions). Underlying operating expenses remained well-controlled, with increased investments targeted to support the growth of Adstiladrin and other opportunities. Thus, operating profit for the year reached €167 million, a decrease of -€24 million (‑13%) versus the prior
Quectel Unveils Versatile Pi Series SBCs to Power Developer Innovation10.3.2026 10:00:00 EET | Press release
Quectel Wireless Solutions, a global end-to-end IoT solutions provider, today announces the launch of its range of Quectel Pi series of single-board computers (SBCs), designed for a broad range of industrial use cases. The portfolio currently includes three compact development platforms - the Quectel Pi M1, L1, and H1 boards - engineered for low power consumption, cost efficiency, and full-stack software support. Designed to accelerate prototyping and product development, they are well suited for embedded applications, IoT solutions, robotics projects, and edge computing deployments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310949640/en/ Quectel unveils versatile Pi series SBCs to power developer innovation “We’re delighted to launch the affordable, versatile, open source Quectel Pi series of SBCs to help developers of real IoT projects in areas such as home automation, robotics, sensors and edge computing to achiev
Expereo Appoints Kevin Brown as Chief Operating Officer to Drive Operational Excellence and Customer-Focused Growth10.3.2026 10:00:00 EET | Press release
Expereo, the world-leading Managed Network as a Service (NaaS) provider, today announces the appointment of Kevin Brown as Chief Operating Officer (COO), reinforcing the company’s focus on operational integration, efficiency, and scaling its customer and supplier-facing functions globally. Brown will assume overall accountability for operational strategy, transformation delivery, and performance across all customer and supplier-facing functions, while working in close partnership with the Digital Office, to deliver on our digital transformation. He brings extensive global operational leadership experience across Telco, Cybersecurity, and SaaS, most recently serving as Global COO of NCC Group, where he built and scaled operating models to drive customer experience, efficiency, and growth. Earlier in his career, Brown led the cybersecurity business at BT, establishing a strong track record of transforming operations into engines of value creation at scale. Kevin Brown, Chief Operating Of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom